Medpace (MEDP) director Robert O. Kraft exercises 33 RSUs, holds 955 shares

Filing Impact

(Neutral)

Filing Sentiment

(Neutral)

Form Type

Rhea-AI Filing Summary

Medpace Holdings, Inc. director Robert O. Kraft exercised restricted stock units into common shares as part of his equity compensation. On June 30, he converted 33 restricted stock units into 33 shares of common stock at a stated price of $0.0000 per share. After this transaction, he directly holds 955 common shares and 64 remaining restricted stock units. These units come from a November 28, 2025 grant of 130 restricted stock units scheduled to vest in four approximately equal installments through December 31, 2026.

Insider Trade Summary

33 shares exercised/converted

Mixed 2 txns

Insider Kraft Robert O.

Role null

Type	Security	Shares	Price	Value
Exercise	Restricted Stock Unit	33	$0.00	--
Exercise	Common Stock	33	$0.00	--

Holdings After Transaction: Restricted Stock Unit — 64 shares (Direct, null); Common Stock — 955 shares (Direct, null)

Footnotes (1)

Each restricted stock unit represents a contingent right to receive one share of MEDP common stock. On November 28, 2025, the Reporting Person was granted 130 restricted stock units vesting in four approximately equal installments on March 31, 2026, June 30, 2026, September 30, 2026 and December 31, 2026.

Key Figures

RSUs exercised: 33 restricted stock units Common shares after transaction: 955 shares RSUs remaining: 64 restricted stock units +3 more

6 metrics

RSUs exercised 33 restricted stock units Converted into 33 common shares on June 30

Common shares after transaction 955 shares Direct holdings following June 30 transaction

RSUs remaining 64 restricted stock units Outstanding after the June 30 conversion

Original RSU grant 130 restricted stock units Granted on November 28, 2025

RSU vesting schedule 4 installments Vesting on Mar 31, Jun 30, Sep 30, Dec 31, 2026

Exercise price per share $0.0000 per share For the 33 RSUs converted to common stock

Key Terms

Restricted Stock Unit, derivative security, contingent right

3 terms

Restricted Stock Unit financial

"On November 28, 2025, the Reporting Person was granted 130 restricted stock units vesting in four approximately equal installments"

A restricted stock unit is a promise from a company to give an employee shares of stock after certain conditions are met, like staying with the company for a set amount of time. It’s like earning a bonus that turns into company stock once you’ve proven your commitment, making it a way to motivate and reward employees.

derivative security financial

"transaction_code_description": "Exercise or conversion of derivative security""

A derivative security is a financial contract whose value comes from the price or performance of something else, such as a stock, bond, commodity, or market index. For investors it acts like an insurance policy or a wager: it can be used to protect against losses, lock in prices, or amplify gains and losses, so it can change a portfolio’s risk and potential return without owning the underlying asset directly.

contingent right financial

"Each restricted stock unit represents a contingent right to receive one share of MEDP common stock."

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google

Form 4 Insider Transactions: What Each Field Means →

Available on EDGAR 07/02/2026 - 04:09 PM Accepted by SEC EDGAR 07/02/2026 - 04:08 PM

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Kraft Robert O.

(Last)

(First)

(Middle)

C/O MEDPACE HOLDINGS, INC.

5375 MEDPACE WAY

(Street)

CINCINNATI

OHIO

45227

(City)

(State)

(Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Medpace Holdings, Inc. [ MEDP ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director	10% Owner
	Officer (give title below)	Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
06/30/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
Common Stock	06/30/2026		M		33	A	⁽¹⁾	955	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
Restricted Stock Unit	⁽¹⁾	06/30/2026		M			33	⁽²⁾	⁽²⁾	Common Stock	33	$0	64	D

Explanation of Responses:

1. Each restricted stock unit represents a contingent right to receive one share of MEDP common stock.

2. On November 28, 2025, the Reporting Person was granted 130 restricted stock units vesting in four approximately equal installments on March 31, 2026, June 30, 2026, September 30, 2026 and December 31, 2026.

Remarks:

	/s/ Stephen P. Ewald, Attorney-in-Fact for Robert O. Kraft	07/02/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Source: View Original Filing on SEC EDGAR

FAQ

What insider transaction did Medpace (MEDP) director Robert O. Kraft report?

Robert O. Kraft reported exercising 33 restricted stock units into 33 shares of Medpace common stock. The transaction, dated June 30, carried a stated price of $0.0000 per share and reflects routine equity compensation activity rather than an open-market stock purchase or sale.

How many Medpace (MEDP) shares does Robert O. Kraft hold after this Form 4?

After the reported transaction, Robert O. Kraft directly holds 955 shares of Medpace common stock. He also holds 64 restricted stock units, which represent additional contingent rights to receive shares as they vest under the company’s equity compensation arrangements.

What are the details of Robert O. Kraft’s Medpace (MEDP) restricted stock unit grant?

On November 28, 2025, Robert O. Kraft was granted 130 restricted stock units in Medpace. These units vest in four approximately equal installments on March 31, 2026, June 30, 2026, September 30, 2026, and December 31, 2026, subject to the grant’s terms and conditions.

Is Robert O. Kraft’s Medpace (MEDP) Form 4 transaction an open-market trade?

No, the Form 4 shows an exercise of derivative securities, specifically restricted stock units converting into common shares at $0.0000 per share. It does not report any open-market purchases or sales, but rather a compensation-related equity vesting event for the director.

What does one Medpace (MEDP) restricted stock unit represent for Robert O. Kraft?

Each restricted stock unit granted to Robert O. Kraft represents a contingent right to receive one share of Medpace common stock. The units convert into shares as they vest over time, according to the specified installment dates and the company’s equity award terms.